Form 4: Cencora Inc. Executive Receives Stock Grant

Cencora, Inc. reports a grant of restricted stock units to Chief Financial Officer Eva C. Boratto.

Summary

• Eva C. Boratto, Chief Financial Officer of Cencora, Inc., was granted 21,304 restricted stock units (RSUs) on June 29, 2026.
• These RSUs were received for no consideration.
• The RSUs will vest in three equal annual installments on June 29, 2027, June 29, 2028, and June 29, 2029.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation event rather than a significant financial or strategic development.

Positives

• Grant of 21,304 restricted stock units to the Chief Financial Officer, indicating continued investment in key executive talent.
• The stock grant is for no consideration, representing a direct benefit to the executive.

Future Outlook

The future outlook is tied to the vesting schedule of the restricted stock units, with portions vesting annually through June 2029.

Industry Context

StockSavvy.ai notes that grants of restricted stock units are a common form of executive compensation in the pharmaceutical and healthcare services industry, used to align executive interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The grant of RSUs is a form of compensation, which impacts dilution and executive alignment with shareholder interests.
• Employees: May signal the company's approach to executive compensation and retention.
• Management: Reinforces the financial incentives for the Chief Financial Officer.

Next Steps

• Vesting of restricted stock units on June 29, 2027, June 29, 2028, and June 29, 2029.

Key Dates

Keywords

Cencora Inc., Form 4, Restricted Stock Units, Executive Compensation, SEC Filing, Insider Trading, Stock Grant, Eva C. Boratto